| Invasive epithelial ovarian cancer survival by histotype and disease stage LC Peres, KL Cushing-Haugen, M Köbel, HR Harris, A Berchuck, ... JNCI: Journal of the National Cancer Institute 111 (1), 60-68, 2019 | 524 | 2019 |
| Idecabtagene vicleucel for relapsed/refractory multiple myeloma: real-world experience from the myeloma CAR T consortium DK Hansen, S Sidana, LC Peres, C Colin Leitzinger, L Shune, ... Journal of Clinical Oncology 41 (11), 2087-2097, 2023 | 193 | 2023 |
| Challenges and opportunities in studying the epidemiology of ovarian cancer subtypes JA Doherty, LC Peres, C Wang, GP Way, CS Greene, JM Schildkraut Current epidemiology reports 4, 211-220, 2017 | 105 | 2017 |
| The Deepwater Horizon Oil Spill and Physical Health among Adult Women in Southern Louisiana: The Women and Their Children’s Health (WaTCH) Study LC Peres, E Trapido, AL Rung, DJ Harrington, E Oral, Z Fang, E Fontham, ... Environmental health perspectives 124 (8), 1208-1213, 2016 | 89 | 2016 |
| Histotype classification of ovarian carcinoma: A comparison of approaches LC Peres, KL Cushing-Haugen, M Anglesio, K Wicklund, R Bentley, ... Gynecologic oncology 151 (1), 53-60, 2018 | 86 | 2018 |
| Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the US, 1995–2005 L Cole, L Polfus, ES Peters PloS one 7 (3), e32657, 2012 | 80 | 2012 |
| Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy CJ Ferreri, MAT Hildebrandt, H Hashmi, LO Shune, JP McGuirk, ... Blood cancer journal 13 (1), 117, 2023 | 70 | 2023 |
| Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma JM Logue, LC Peres, H Hashmi, CM Colin-Leitzinger, AM Shrewsbury, ... Blood Advances 6 (24), 6109-6119, 2022 | 70 | 2022 |
| High levels of C-reactive protein are associated with an increased risk of ovarian cancer: results from the Ovarian Cancer Cohort Consortium LC Peres, AR Mallen, MK Townsend, EM Poole, B Trabert, NE Allen, ... Cancer research 79 (20), 5442-5451, 2019 | 55 | 2019 |
| Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies LC Peres, H Risch, KL Terry, PM Webb, MT Goodman, AH Wu, AJ Alberg, ... International journal of epidemiology 47 (2), 460-472, 2018 | 54 | 2018 |
| Dietary inflammatory index and risk of epithelial ovarian cancer in African American women LC Peres, EV Bandera, B Qin, KA Guertin, N Shivappa, JR Hebert, ... International journal of cancer 140 (3), 535-543, 2017 | 49 | 2017 |
| Association between body powder use and ovarian cancer: the African American Cancer Epidemiology Study (AACES) JM Schildkraut, SE Abbott, AJ Alberg, EV Bandera, JS Barnholtz-Sloan, ... Cancer Epidemiology, Biomarkers & Prevention 25 (10), 1411-1417, 2016 | 49 | 2016 |
| Predictors of survival trajectories among women with epithelial ovarian cancer LC Peres, S Sinha, MK Townsend, BL Fridley, BY Karlan, SK Lutgendorf, ... Gynecologic oncology 156 (2), 459-466, 2020 | 42 | 2020 |
| Targetable immune regulatory molecule expression in high-grade serous ovarian carcinomas in African American Women: a study of PD-L1 and IDO in 112 cases from the African … AM Mills, LC Peres, A Meiss, KL Ring, SC Modesitt, SE Abbott, AJ Alberg, ... International Journal of Gynecological Pathology 38 (2), 157-170, 2019 | 42 | 2019 |
| Challenges and opportunities in the statistical analysis of multiplex immunofluorescence data CM Wilson, OE Ospina, MK Townsend, J Nguyen, C Moran Segura, ... Cancers 13 (12), 3031, 2021 | 39 | 2021 |
| Perceived discrimination, trust in physicians, and prolonged symptom duration before ovarian cancer diagnosis in the African American Cancer Epidemiology Study MA Mullins, LC Peres, AJ Alberg, EV Bandera, JS Barnholtz‐Sloan, ... Cancer 125 (24), 4442-4451, 2019 | 38 | 2019 |
| Analgesic medication use and risk of epithelial ovarian cancer in African American women LC Peres, F Camacho, SE Abbott, AJ Alberg, EV Bandera, ... British journal of cancer 114 (7), 819-825, 2016 | 37 | 2016 |
| Surveillance of high-grade cervical cancer precursors (CIN III/AIS) in four population-based cancer registries, United States, 2009–2012 M Watson, A Soman, EW Flagg, E Unger, D Deapen, VW Chen, LC Peres, ... Preventive medicine 103, 60-65, 2017 | 35 | 2017 |
| Safety and efficacy of standard of care (SOC) ciltacabtagene autoleucel (Cilta-cel) for relapsed/refractory multiple myeloma (RRMM). DK Hansen, KK Patel, LC Peres, MH Kocoglu, L Shune, G Simmons, ... Journal of Clinical Oncology 41 (16_suppl), 8012-8012, 2023 | 34 | 2023 |
| Racial/ethnic disparities in ovarian cancer research LC Peres, JM Schildkraut Advances in cancer research 146, 1-21, 2020 | 32 | 2020 |
